Evidence map›Paper›PMID 34426708›Full record

ReviewNature protocols2021

Tutorial: using nanoneedles for intracellular delivery.

Ciro Chiappini, Yaping Chen, Stella Aslanoglou, Anna Mariano, Valentina Mollo, Huanwen Mu, Enrica De Rosa, Gen He, Ennio Tasciotti, Xi Xie and 4 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Poking Pluripotency: Nanoinjection Into Human iPSCs.Advanced materials (Deerfield Beach, Fla.) · 2026
    Article
  6. Article
  7. Just a little prick: careful cell contacts enabled by ceramic nanostraws.Pflugers Archiv : European journal of physiology · 2026
    Article
  8. Article
  9. Article
  10. The Rise of Mechanobiology for Advanced Cell Engineering and Manufacturing.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Long-Term Diabetic Retinopathy Treatment Using Silicon Nanoneedles.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  19. Article
  20. Polymeric nanocarriers for therapeutic gene delivery.Asian journal of pharmaceutical sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ciro Chiappini *Centre for Craniofacial and Regenerative Biology, King's College London, London, UK. ciro.chiappini@kcl.ac.uk.ORCID http://orcid.org/0000-0002-9893-4359
Yaping Chen *Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0002-1940-0966
Stella AslanoglouMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Anna MarianoCenter for Advanced Biomaterials for Healthcare, Istituto Italiano di Tecnologia, Naples, Italy.
Valentina MolloCenter for Advanced Biomaterials for Healthcare, Istituto Italiano di Tecnologia, Naples, Italy.
Huanwen MuSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.ORCID http://orcid.org/0000-0003-0122-6952
Enrica De RosaCenter for Musculoskeletal Regeneration, Orthopedics & Sports Medicine, Houston Methodist Research Institute, Houston, TX, USA.
Gen HeState Key Laboratory of Optoelectronic Materials and Technologies, Guangdong Province Key Laboratory of Display Material and Technology, School of Electronics and Information Technology, Sun Yat-sen University, Guangzhou, China.
Ennio TasciottiIRCCS San Raffaele Pisana Hospital, Rome, Italy.
Xi XieState Key Laboratory of Optoelectronic Materials and Technologies, Guangdong Province Key Laboratory of Display Material and Technology, School of Electronics and Information Technology, Sun Yat-sen University, Guangzhou, China. xiexi27@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0001-7406-8444
Francesca SantoroCenter for Advanced Biomaterials for Healthcare, Istituto Italiano di Tecnologia, Naples, Italy. francesca.santoro@iit.it.ORCID http://orcid.org/0000-0001-7323-9504
Wenting ZhaoSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore. wtzhao@ntu.edu.sg.ORCID http://orcid.org/0000-0002-6143-5185
Nicolas H VoelckerMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia. nicolas.voelcker@monash.edu.
Roey ElnathanMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia. roey.elnathan@monash.edu.ORCID http://orcid.org/0000-0002-0654-0097

Funding

Medical Research Council MC_PC_16048National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/R001006/1
6 · The paper itself

Abstract

Intracellular delivery of advanced therapeutics, including biologicals and supramolecular agents, is complex because of the natural biological barriers that have evolved to protect the cell. Efficient delivery of therapeutic nucleic acids, proteins, peptides and nanoparticles is crucial for clinical adoption of emerging technologies that can benefit disease treatment through gene and cell therapy. Nanoneedles are arrays of vertical high-aspect-ratio nanostructures that can precisely manipulate complex processes at the cell interface, enabling effective intracellular delivery. This emerging technology has already enabled the development of efficient and non-destructive routes for direct access to intracellular environments and delivery of cell-impermeant payloads. However, successful implementation of this technology requires knowledge of several scientific fields, making it complex to access and adopt by researchers who are not directly involved in developing nanoneedle platforms. This presents an obstacle to the widespread adoption of nanoneedle technologies for drug delivery. This tutorial aims to equip researchers with the knowledge required to develop a nanoinjection workflow. It discusses the selection of nanoneedle devices, approaches for cargo loading and strategies for interfacing to biological systems and summarises an array of bioassays that can be used to evaluate the efficacy of intracellular delivery.

Indexed as

Drug Delivery SystemsAnimalsHumansNanostructuresNanotechnology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.